Skip to main content

Volume 17 Supplement 1

Abstracts from “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network

Meeting abstracts

Symposium was sponsored by Riga Stradins University (RSU), Riga, Latvia; Peoples Friendship University of Russia (RUDN University); R&D companies "BD Biosciences" and "Helicon"; research journals "Infectious Agents and Cancer" (BMC, Spinger Nature) and "Cancers" (MDPI, Bazel) and by the Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to M. Isaguliants at RSU, Riga, Latvia.

VirtualDecember 16-17, 2021

Edited by Maria Isaguliants, Natalia Petrakova and Franco Buonaguro.


Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.1
    5-year Journal Impact Factor: 3.3
    Source Normalized Impact per Paper (SNIP): 0.810
    SCImago Journal Rank (SJR): 0.424

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 112

    Usage 2023
    Downloads: 687,750
    Altmetric mentions: 813

What is trending?

Altmetric




               Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.